| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 372 | 2017 |
| Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets DK Singh, B Singh, SR Ganatra, M Gazi, J Cole, R Thippeshappa, ... Nature microbiology 6 (1), 73-86, 2021 | 177 | 2021 |
| Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis. MGBA Maryandyshev A, Pontali E, Tiberi S, Akkerman O, Ganatra S, Sadutshang ... Emerg Infect Dis. 23 (10), 2017 | 64 | 2017 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study O Akkerman, A Aleksa, JW Alffenaar, NH Al-Marzouqi, M Arias-Guillén, ... International journal of infectious diseases 83, 72-76, 2019 | 59 | 2019 |
| Pulmonary Mycobacterium tuberculosis control associates with CXCR3-and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment U Shanmugasundaram, AN Bucsan, SR Ganatra, C Ibegbu, M Quezada, ... JCI insight 5 (14), 2020 | 55 | 2020 |
| Chronic immune activation in TB/HIV co-infection R Sharan, AN Bucşan, S Ganatra, M Paiardini, M Mohan, S Mehra, ... Trends in microbiology 28 (8), 619-632, 2020 | 52 | 2020 |
| Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans EW Tucker, L Pieterse, MD Zimmerman, ZF Udwadia, CA Peloquin, ... Antimicrobial agents and chemotherapy 63 (10), 10.1128/aac. 00913-19, 2019 | 45 | 2019 |
| Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India ZF Udwadia, S Ganatra, JB Mullerpattan European Respiratory Journal 49 (3), 2017 | 40 | 2017 |
| Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model SR Ganatra, AN Bucşan, X Alvarez, S Kumar, A Chatterjee, M Quezada, ... The Journal of clinical investigation 130 (10), 5171-5179, 2020 | 37 | 2020 |
| Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery SE Borisov, L d'Ambrosio, R Centis, S Tiberi, K Dheda, JW Alffenaar, ... Journal of Infection 78 (1), 35-39, 2019 | 37 | 2019 |
| SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species DK Singh, SR Ganatra, B Singh, J Cole, KJ Alfson, E Clemmons, M Gazi, ... BioRxiv, 2020.06. 05.136481, 2020 | 35 | 2020 |
| Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India JB Mullerpattan, ZZ Udwadia, RA Banka, SR Ganatra, ZF Udwadia indian journal of tuberculosis 66 (1), 87-91, 2019 | 33 | 2019 |
| The voltage-gated proton channel Hv1 promotes microglia-astrocyte communication and neuropathic pain after peripheral nerve injury J Peng, MH Yi, H Jeong, PP McEwan, J Zheng, G Wu, S Ganatra, Y Ren, ... Molecular brain 14, 1-18, 2021 | 24 | 2021 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of multidrug and extensively drug-resistant tuberculosis: a multicentre study SE Borisov, K Dheda, M Enwerem, R Romero Leyet, L D’Ambrosio, ... Eur Respir J 49 (5), 1700387, 2017 | 22 | 2017 |
| Visualizing the dynamics of tuberculosis pathology using molecular imaging AA Ordonez, EW Tucker, CJ Anderson, CL Carter, S Ganatra, D Kaushal, ... The Journal of clinical investigation 131 (5), 2021 | 20 | 2021 |
| Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic ZF Udwadia, JA Tornheim, S Ganatra, A DeLuca, CS Rodrigues, A Gupta BMC infectious diseases 19, 1-9, 2019 | 18 | 2019 |
| Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates MA Stammes, JH Lee, L Meijer, T Naninck, LA Doyle-Meyers, AG White, ... Trends in Molecular Medicine 28 (2), 123-142, 2022 | 15 | 2022 |
| Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model R Sharan, SR Ganatra, AN Bucsan, J Cole, DK Singh, X Alvarez, ... The Journal of Clinical Investigation 132 (3), 2022 | 11 | 2022 |
| Myeloid-derived suppressor cells mediate T cell dysfunction in nonhuman primate TB granulomas B Singh, DK Singh, SR Ganatra, RA Escobedo, S Khader, LS Schlesinger, ... Mbio 12 (6), e03189-21, 2021 | 11 | 2021 |
| members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Surveillance of adverse events in the treatment of drug-resistant … O Akkerman, A Aleksa, JW Alffenaar, NH Al-Marzouqi, M Arias-Guillén, ... Int J Infect Dis 83, 72-6, 2019 | 11 | 2019 |
Deepak Kaushal, PhDProfessor and Director, Southwest National Primate Research Center, Texas Biomedical Research在 txbiomed.org 的电子邮件经过验证
Deepak Kaushal, PhDProfessor and Director, Southwest National Primate Research Center, Texas Biomedical Research在 txbiomed.org 的电子邮件经过验证
zarir udwadiaPhysician Hinduja Hospital